You've Funded the Next Generation of Prostate Cancer Researchers

Auteur : Movember
Thanks to your hard work, four rising stars of the prostate cancer research world have been funded!

Now in its fourth year, the Rising Star award recognizes outstanding new prostate cancer researchers and supports their pursuit of groundbreaking research. The Rising Star award, in partnership with Prostate Cancer Canada, represents a total investment of $1.3 million, with each award granted a maximum of $450,000 over three years.  

The 2016 Movember Rising Stars in prostate cancer research include:

Housheng He, University Health Network Toronto, ON
Dr. He will utilize the whole genome approach to decode the noncoding regions of the human genome that is largely unexplored, with the goal of identifying targeted prostate cancer medicine tailored to the unique genetic identity of each patient.

Hon Leong, Lawson Health Research Institute London, ON
Dr. Leong’s research will deliver novel drugs that halt the spread of prostate cancer to determine if they are effective in stopping metastasis in the majority of prostate cancer cell lines, with the goal of representing a new class of therapies for the treatment of patients with advanced prostate cancer.

Alexander Wyatt, Vancouver Prostate Centre, BC
By analyzing the small fragments of tumor DNA that are shed into the bloodstream by cancers, Dr. Wyatt’s research will identify prostate cancer patients that could benefit from treatment with new or different drugs.

Stay up to date and learn more about our prostate cancer funding here!